{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:26:05Z","timestamp":1784366765496,"version":"3.55.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejim.2023.07.016","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:58:40Z","timestamp":1689998320000},"page":"8-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?"],"prefix":"10.1016","volume":"117","author":[{"given":"Abdul-Quddus","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad A.","family":"Abdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redhwan M.","family":"Mareai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0001","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2796.2012.02591.x","article-title":"Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA)","volume":"273","author":"Beltrame","year":"2013","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0002","first-page":"143","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0003","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(10)80091-9","article-title":"Myocardial infarction with minimal coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group","volume":"17","author":"Kereiakes","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.ejim.2023.07.016_bib0004","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejim.2023.07.016_bib0005","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ejim.2023.07.016_bib0006","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.amjcard.2012.11.011","article-title":"Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)","volume":"111","author":"Larsen","year":"2013","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.ejim.2023.07.016_bib0007","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.07.016_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2019.02.036","article-title":"Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: clinical features, treatment and 1year follow-up","volume":"287","author":"Abdu","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2023.07.016_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.681978","article-title":"Low free triiodothyronine as a predictor of poor prognosis in patients with myocardial infarction with non-obstructive coronary arteries","volume":"12","author":"Abdu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"19","key":"10.1016\/j.ejim.2023.07.016_bib0010","first-page":"E475","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries (vol 131, pg 861, 2015)","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.07.016_bib0011","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pcad.2021.08.004","article-title":"The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries","volume":"68","author":"Montone","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100761","article-title":"Myocardial infarction without obstructive coronary artery disease (MINOCA): a practical guide for clinicians","volume":"46","author":"Ciliberti","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ejim.2023.07.016_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.781485","article-title":"The pivotal role of invasive functional assessment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA)","volume":"8","author":"Mangiacapra","year":"2021","journal-title":"Front Cardiovasc Med."},{"issue":"21","key":"10.1016\/j.ejim.2023.07.016_bib0014","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Bairey Merz","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0017","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/cvr\/cvaa003","article-title":"ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease","volume":"116","author":"Padro","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0018","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2023.07.016_bib0019","article-title":"Prognostic significance of coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","author":"Mohammed","year":"2023","journal-title":"Can J Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.ejim.2023.07.016_bib0021","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ejim.2023.07.016_bib0022","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1093\/eurheartj\/ehs246","article-title":"Coronary microvascular dysfunction in the clinical setting: from mystery to reality","volume":"33","author":"Herrmann","year":"2012","journal-title":"Eur Heart J"},{"issue":"45","key":"10.1016\/j.ejim.2023.07.016_bib0023","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/eurheartj\/ehv100","article-title":"Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation","volume":"36","author":"Pries","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0024","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/micc.12040","article-title":"Diversity in mechanisms of endothelium-dependent vasodilation in health and disease","volume":"20","author":"Durand","year":"2013","journal-title":"Microcirculation"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/07853890.2011.585658","article-title":"Nitric oxide: orchestrator of endothelium-dependent responses","volume":"44","author":"Feletou","year":"2012","journal-title":"Ann Med"},{"issue":"41","key":"10.1016\/j.ejim.2023.07.016_bib0026","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/eurheartj\/eht351","article-title":"Endothelial dysfunction over the course of coronary artery disease","volume":"34","author":"Gutierrez","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2023.07.016_bib0027","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fphar.2018.01308","article-title":"The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches","volume":"9","author":"Ooi","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejim.2023.07.016_bib0028","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fphar.2017.00798","article-title":"NF-kappabeta: a potential target in the management of vascular complications of diabetes","volume":"8","author":"Suryavanshi","year":"2017","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0029","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5830\/CVJA-2011-068","article-title":"Endothelial dysfunction: the early predictor of atherosclerosis","volume":"23","author":"Mudau","year":"2012","journal-title":"Cardiovasc J Afr"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0031","first-page":"183","article-title":"Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome","volume":"1","author":"Hadi","year":"2005","journal-title":"Vasc Health Risk Manag"},{"issue":"8828","key":"10.1016\/j.ejim.2023.07.016_bib0032","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"Celermajer","year":"1992","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejim.2023.07.016_bib0033","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"Fichtlscherer","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejim.2023.07.016_bib0034","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0735-1097(01)01212-8","article-title":"Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries","volume":"37","author":"Al Suwaidi","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00004872-200303000-00030","article-title":"Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients","volume":"21","author":"Rizzoni","year":"2003","journal-title":"J Hypertens"},{"issue":"5","key":"10.1016\/j.ejim.2023.07.016_bib0036","first-page":"575","article-title":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can J Cardiol"},{"issue":"25","key":"10.1016\/j.ejim.2023.07.016_bib0037","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2174\/1381612824666180702154129","article-title":"Dyslipidemias and Microcirculation","volume":"24","author":"Padro","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.ejim.2023.07.016_bib0038","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ejhf.497","article-title":"Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation","volume":"18","author":"Ter Maaten","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0039","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/CIRCRESAHA.108.172528","article-title":"Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis","volume":"102","author":"Sorop","year":"2008","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.ejim.2023.07.016_bib0040","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER study","volume":"5","author":"Mygind","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0042","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0043","first-page":"284","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0044","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000063121","article-title":"The coronary slow flow phenomenon\u2013a new coronary microvascular disorder","volume":"97","author":"Beltrame","year":"2002","journal-title":"Cardiology"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijcard.2007.06.010","article-title":"\"slow coronary flow\" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances","volume":"127","author":"Fineschi","year":"2008","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2023.07.016_bib0046","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2023.07.016_bib0047","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejim.2022.11.026","article-title":"Prognostic implication of coronary slow flow assessed by cTFC in patients with myocardial infarction with Non-obstructive coronary arteries","volume":"108","author":"Mareai","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"25","key":"10.1016\/j.ejim.2023.07.016_bib0048","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2023.07.016_bib0049","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jacc.2015.12.053","article-title":"Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis","volume":"67","author":"Lee","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0050","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jcin.2015.04.028","article-title":"Intracoronary adenosine: dose-response relationship with hyperemia","volume":"8","author":"Adjedj","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.ejim.2023.07.016_bib0051","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel index for invasively assessing the coronary microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.ejim.2023.07.016_bib0052","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2023.07.016_bib0053","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005361","article-title":"Invasive assessment of the coronary microvasculature: the index of microcirculatory resistance","volume":"10","author":"Fearon","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ejim.2023.07.016_bib0054","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","article-title":"Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease","volume":"131","author":"Lee","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/heartjnl-2017-311431","article-title":"Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction","volume":"104","author":"de Waard","year":"2018","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0056","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001786","article-title":"Doppler-derived intracoronary physiology indices predict the occurrence of microvascular injury and microvascular perfusion deficits after angiographically successful primary percutaneous coronary intervention","volume":"8","author":"Teunissen","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejim.2023.07.016_bib0057","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2023.07.016_bib0058","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.atherosclerosis.2020.12.008","article-title":"Coronary provocative tests in the catheterization laboratory: pathophysiological bases, methodological considerations and clinical implications","volume":"318","author":"Montone","year":"2021","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0059","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2013.10.038","article-title":"Provocative testing for coronary reactivity and spasm","volume":"63","author":"Zaya","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00392-019-01523-w","article-title":"Clinical, angiographic and echocardiographic correlates of epicardial and microvascular spasm in patients with myocardial ischaemia and non-obstructive coronary arteries","volume":"109","author":"Montone","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0061","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00392-019-01507-w","article-title":"Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA)","volume":"109","author":"Pirozzolo","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0062","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/clc.22369","article-title":"Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in Japan","volume":"38","author":"Isogai","year":"2015","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0063","first-page":"91","article-title":"Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests","volume":"39","author":"Montone","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0064","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.4244\/EIJ-D-21-00971","article-title":"Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.ejim.2023.07.016_bib0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00392-019-01472-4","article-title":"Coronary microvascular dysfunction in patients with acute coronary syndrome and no obstructive coronary artery disease","volume":"108","author":"De Vita","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0066","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004875","article-title":"Incremental value of transthoracic doppler echocardiography-assessed coronary flow reserve in patients with suspected myocardial ischemia undergoing myocardial perfusion scintigraphy","volume":"6","author":"Gan","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.ejim.2023.07.016_bib0067","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jacc.2007.06.027","article-title":"Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria","volume":"50","author":"Cortigiani","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2023.07.016_bib0068","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.amjcard.2007.06.060","article-title":"Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter","volume":"100","author":"Rigo","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2023.07.016_bib0069","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jcmg.2010.04.007","article-title":"Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health","volume":"3","author":"Schindler","year":"2010","journal-title":"JACC Cardiovasc Imag"},{"issue":"1","key":"10.1016\/j.ejim.2023.07.016_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2459\/JCM.0b013e328351680f","article-title":"Methods to investigate coronary microvascular function in clinical practice","volume":"14","author":"Lanza","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0071","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2023.07.016_bib0072","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jcmg.2018.12.023","article-title":"Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries","volume":"12","author":"Dastidar","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0073","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002481","article-title":"Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation","volume":"8","author":"Thomson","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ejim.2023.07.016_bib0074","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcmg.2020.09.034","article-title":"Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance","volume":"14","author":"Zhou","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2023.07.016_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12968-017-0397-8","article-title":"Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease","volume":"19","author":"Levelt","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0076","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00392-018-1279-2","article-title":"Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging","volume":"107","author":"Bietenbeck","year":"2018","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"10.1016\/j.ejim.2023.07.016_bib0077","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/clc.22571","article-title":"Stress cardiac MRI in women with myocardial infarction and nonobstructive coronary artery disease","volume":"39","author":"Mauricio","year":"2016","journal-title":"Clin Cardiol"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0078","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006427","article-title":"Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging","volume":"10","author":"Feher","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Supplement_1","key":"10.1016\/j.ejim.2023.07.016_bib0079","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeaa356.338","article-title":"The usage CZT SPECT to assess myocardial blood flow and flow reserve in myocardial infarction with non-obstructive coronary arteries patients","volume":"22","author":"Maltseva","year":"2021","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"Supplement_1","key":"10.1016\/j.ejim.2023.07.016_bib0080","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeaa356.339","article-title":"Dynamic SPECT with assessment myocardial blood flow and coronary flow reserve in MINOCA patients: comparison with cardiac magnetic resonance","volume":"22","author":"Mochula","year":"2021","journal-title":"Eur Heart J - Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ejim.2023.07.016_bib0081","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12872-022-02985-z","article-title":"Relationships between indicators of prothrombotic activity and coronary microvascular dysfunction in patients with myocardial infarction with obstructive and non-obstructive coronary artery disease","volume":"22","author":"Vorobeva","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ejim.2023.07.016_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.605356","article-title":"Coronary angiography-derived index of microvascular resistance","volume":"11","author":"Ai","year":"2020","journal-title":"Front Physiol"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0083","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/cvr\/cvz289","article-title":"Accuracy of computational pressure-fluid dynamics applied to coronary angiography to derive fractional flow reserve: FLASH FFR","volume":"116","author":"Li","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejim.2023.07.016_bib0084","article-title":"Diagnostic performance and prognostic impact of coronary angiography-based Index of Microcirculatory Resistance assessment: a systematic review and meta-analysis","author":"Li","year":"2022","journal-title":"Catheter Cardiovasc. Interv"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10554-020-01831-7","article-title":"Angiography-derived index of microcirculatory resistance as a novel, pressure-wire-free tool to assess coronary microcirculation in ST elevation myocardial infarction","volume":"36","author":"De Maria","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.ejim.2023.07.016_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2021.05.027","article-title":"Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries","author":"Abdu","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"15","key":"10.1016\/j.ejim.2023.07.016_bib0087","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jcin.2021.05.027","article-title":"Functional coronary angiography-derived index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction","volume":"14","author":"Choi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0088","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0089","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.120.052008","article-title":"Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women","volume":"143","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0090","first-page":"202","article-title":"Lesion characteristics and prognosis of acute coronary syndrome without angiographically significant coronary artery stenosis","volume":"21","author":"Taruya","year":"2019","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"issue":"9110","key":"10.1016\/j.ejim.2023.07.016_bib0091","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(97)07329-7","article-title":"Angina pectoris caused by coronary microvascular spasm","volume":"351","author":"Mohri","year":"1998","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ejim.2023.07.016_bib0092","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020535","article-title":"Interplay between myocardial bridging and coronary spasm in patients with myocardial ischemia and non-obstructive coronary arteries: pathogenic and prognostic implications","volume":"10","author":"Montone","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.ejim.2023.07.016_bib0093","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2019.08.1056","article-title":"Coronary functional abnormalities in patients with angina and nonobstructive coronary artery disease","volume":"74","author":"Suda","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ejim.2023.07.016_bib0094","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.015834","article-title":"Coronary flow reserve in patients with prior spontaneous coronary artery dissection and recurrent angina","volume":"9","author":"Sedlak","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","article-title":"Coronary microvascular dysfunction in hypertrophy and heart failure","volume":"116","author":"Camici","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0096","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","article-title":"Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography","volume":"17","author":"Camici","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0097","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","article-title":"Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy","volume":"349","author":"Cecchi","year":"2003","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0098","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41569-018-0011-2","article-title":"Pathophysiological coronary and microcirculatory flow alterations in aortic stenosis","volume":"15","author":"Michail","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ejim.2023.07.016_bib0099","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1475-097X.2009.00893.x","article-title":"Long-term prognostic role of coronary flow velocity reserve in patients with aortic valve stenosis - insights from the SZEGED Study","volume":"29","author":"Nemes","year":"2009","journal-title":"Clin Physiol Funct Imaging"},{"issue":"9","key":"10.1016\/j.ejim.2023.07.016_bib0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/europace\/euaa156","article-title":"Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connection","volume":"22","author":"Kosmas","year":"2020","journal-title":"Europace"},{"issue":"Supplement_1","key":"10.1016\/j.ejim.2023.07.016_bib0101","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euac053.154","article-title":"Supraventricular arrhythmias in MINOCA patients","volume":"24","author":"Santos","year":"2022","journal-title":"EP Europace"},{"issue":"8","key":"10.1016\/j.ejim.2023.07.016_bib0102","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014850","article-title":"Coronary endothelial dysfunction is associated with increased risk of incident atrial fibrillation","volume":"9","author":"Corban","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.ejim.2023.07.016_bib0103","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009218","article-title":"Myocardial perfusion is impaired and relates to cardiac dysfunction in patients with atrial fibrillation both before and after successful catheter ablation","volume":"7","author":"Wijesurendra","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.ejim.2023.07.016_bib0104","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehm246","article-title":"Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation","volume":"28","author":"Range","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ejim.2023.07.016_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ehjqcco\/qcv014","article-title":"Angina frequency after acute myocardial infarction in patients without obstructive coronary artery disease","volume":"1","author":"Grodzinsky","year":"2015","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"7","key":"10.1016\/j.ejim.2023.07.016_bib0106","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/eurheartj\/ehz403","article-title":"Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population","volume":"41","author":"Dreyer","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ejim.2023.07.016_bib0107","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003443","article-title":"Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines)","volume":"10","author":"Smilowitz","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2023.07.016_bib0108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2018.04.004","article-title":"Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study","volume":"264","author":"Bainey","year":"2018","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0109","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cvr\/cvaa009","article-title":"The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditions","volume":"116","author":"Konst","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"17","key":"10.1016\/j.ejim.2023.07.016_bib0110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"issue":"23 Pt A","key":"10.1016\/j.ejim.2023.07.016_bib0111","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in Angina: the CorMicA Trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2023.07.016_bib0112","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.amjmed.2017.12.008","article-title":"Myocardial infarction with nonobstructive coronary arteries: the importance of achieving secondary prevention targets","volume":"131","author":"Eggers","year":"2018","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejim.2023.07.016_bib0113","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ejim.2023.07.016_bib0114","first-page":"522","article-title":"Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function","volume":"24","author":"Eshtehardi","year":"2012","journal-title":"J Invasive Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2023.07.016_bib0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ehjcvp\/pvu020","article-title":"Pharmacotherapy for coronary microvascular dysfunction","volume":"1","author":"Ong","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.ejim.2023.07.016_bib0116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2020.11.040","article-title":"Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): insights from a multicentre national registry","volume":"327","author":"Ciliberti","year":"2021","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2023.07.016_bib0117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(02)02632-3","article-title":"Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm","volume":"41","author":"Mohri","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ejim.2023.07.016_bib0118","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0119","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0120","first-page":"1094","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes","volume":"374","author":"Zinman","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejim.2023.07.016_bib0121","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.4244\/EIJ-D-22-00178","article-title":"Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial","volume":"18","author":"Montone","year":"2022","journal-title":"EuroIntervention"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:39:43Z","timestamp":1760607583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523002431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":121,"alternative-id":["S0953620523002431"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.07.016","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}